Marathon Petroleum vs Valero Energy MPC vs VLO
Marathon Petroleum and Valero Energy on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.
MPCVLO
What differs most
- Trailing P/E: Marathon Petroleum 16.3×, Valero Energy 9.6×.
- Operating margin: Valero Energy 12.9%, Marathon Petroleum 8.0%.
- Net margin: Valero Energy 8.9%, Marathon Petroleum 5.6%.
- Debt / equity: Marathon Petroleum 1.8×, Valero Energy 1.1×.
Price return
2025-10-26 → 2026-10-26
MPC+139.9%
VLO+149.5%
Profile
latestSector
Energy
Energy
Industry
Oil & Gas Refining & Marketing
Oil & Gas Refining & Marketing
Market value
$132.17B
$122.88B
Enterprise value
$158.69B
$148.46B
Employees
18,500
9,785
Revenue per employee (TTM)
$8.3M
$14.9M
Our models
nightlythe valuation on each stock's pagePrice vs model
70% overvalued vs model
165% overvalued vs model
Model range
$140–923
$102–384
Models in the headline
1
1
FCF growth priced in, at a 10% return
19.4%
14.2%
Every model, its assumptions and its range: MPC valuation · VLO valuation. The growth priced in, at any return: MPC reverse DCF · VLO reverse DCF.
Trading
close 2026-10-26Last close
$470.64
$426.76
52-week high
$484.97
$459.78
52-week low
$162.63
$161.94
Price vs 52-week high
−3.0%
−7.2%
Price vs 52-week low
+189.4%
+163.5%
Average daily volume / shares
0.8%
1.0%
Beta
0.54
0.59
Returns
to 2026-10-261 month
+19.6%
+10.2%
3 months
+52.2%
+41.1%
6 months
+110.0%
+80.9%
Year to date
+189.4%
+162.2%
1 year
+139.9%
+149.5%
1 year, dividends added
+141.9%
+152.3%
2 years
+208.9%
+222.3%
Valuation
MPC price × TTM to Jun 2026 · VLO price × TTM to Sep 2026P/E (TTM)
16.3×
9.6×
P/E on consensus EPS (next FY)
7.2×
7.7×
Price / sales
0.9×
0.8×
EV / sales
1.0×
1.0×
EV / EBITDA
9.1×
7.1×
Price / book
6.9×
4.0×
Price / free cash flow (FY)
27.7×
24.4×
Free-cash-flow yield (FY)
3.6%
4.1%
Growth
TTM and FY2025Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+36.3%
+30.8%
Revenue, 3-year CAGR
−9.2%
−11.4%
Revenue, 5-year CAGR
13.7%
13.6%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+393.3%
+636.7%
EPS, 3-year CAGR
−22.1%
−36.1%
Free cash flow, 3-year CAGR
−30.1%
−22.7%
Diluted shares, 3-year change
−40.9%
−22.0%
Profitability
MPC TTM to Jun 2026 · VLO TTM to Sep 2026Gross margin (FY)†
7.5%
4.4%
Operating margin
8.0%
12.9%
EBITDA margin
11.3%
14.3%
Net margin
5.6%
8.9%
Free-cash-flow margin (FY)
3.6%
4.1%
Return on equity
44.8%
41.6%
Return on assets
9.1%
74.2%
Asset turnover
1.63
8.34
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.
Balance sheet
MPC MRQ Jun 2026 · VLO MRQ Sep 2026Cash
$7.77B
$9.84B
Total debt
$34.29B
$35.42B
Net debt
$26.52B
$25.59B
Debt / equity
1.8×
1.1×
Net debt / EBITDA (TTM)
1.5×
1.2×
Interest coverage (FY)
4.1×
7.8×
Current ratio (FY)
1.26
1.65
Dividends
trailing 12 monthsDividend yield
0.8%
1.1%
Dividends per share
$4.00
$4.73
Payout ratio (of TTM EPS)
13.8%
10.7%
Dividend per share, 5-year CAGR
11.5%
3.8%
Frequency
Quarterly
Quarterly
Ownership and activity
last 90 days · latest 13FTracked superinvestors holding (13F)
4
2
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$9.8M
$0
Analyst upgrades
0
0
Analyst downgrades
1
2
Statements
MPC income TTM to Jun 2026 · cash flow FY2025 · VLO income TTM to Sep 2026 · cash flow FY2025Revenue
$153.94B
$145.50B
EBITDA
$17.44B
$20.87B
Operating income
$12.24B
$18.71B
Net income
$8.55B
$12.95B
EPS (diluted)
$28.96
$44.39
Operating cash flow
$8.25B
$5.83B
Capital expenditure
−$3.49B
−$796.0M
Free cash flow
$4.77B
$5.03B
Dividends paid
$1.14B
$1.41B
Keep comparing
Statements, prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.